+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Legal Marijuana - Global Market Trajectory & Analytics

  • ID: 5309489
  • Report
  • April 2021
  • Region: Global
  • 146 pages
  • Global Industry Analysts, Inc
Global Legal Marijuana Market to Reach $91.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Legal Marijuana estimated at US$24.2 Billion in the year 2020, is projected to reach a revised size of US$91.2 Billion by 2027, growing at a CAGR of 20.9% over the period 2020-2027. Medical Marijuana, one of the segments analyzed in the report, is projected to record 20.6% CAGR and reach US$69 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Recreational Marijuana segment is readjusted to a revised 21.8% CAGR for the next 7-year period.



The U.S. Market is Estimated at $7.2 Billion, While China is Forecast to Grow at 20.1% CAGR

The Legal Marijuana market in the U.S. is estimated at US$7.2 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$15.6 Billion by the year 2027 trailing a CAGR of 20.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 18.7% and 18.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 15.4% CAGR.

Select Competitors (Total 46 Featured):
  • Aphria Inc.
  • Aurora Cannabis, Inc.
  • Beacon Medical
  • Canopy Growth Corporation
  • Cronos Group
  • OrganiGram Holdings, Inc.
  • Tikun Olam Ltd.
  • Tilray, Inc.
  • Wayland Group Corporation
Note: Product cover images may vary from those shown
I. METHODOLOGY

II. EXECUTIVE SUMMARY
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Table 1: World Current & Future Analysis for Legal Marijuana by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 2: World 7-Year Perspective for Legal Marijuana by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
  • Table 3: World Current & Future Analysis for Medical Marijuana by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 4: World 7-Year Perspective for Medical Marijuana by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 5: World Current & Future Analysis for Recreational Marijuana by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 6: World 7-Year Perspective for Recreational Marijuana by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 7: World Current & Future Analysis for Chronic Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 8: World 7-Year Perspective for Chronic Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 9: World Current & Future Analysis for Mental Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 10: World 7-Year Perspective for Mental Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 11: World Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 12: World 7-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 13: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 14: World 7-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
III. MARKET ANALYSIS
  • Table 15: USA Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 16: USA 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
  • Table 17: USA Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 18: USA 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • Table 19: Canada Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 20: Canada 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
  • Table 21: Canada Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 22: Canada 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • Table 23: Japan Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 24: Japan 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
  • Table 25: Japan Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 26: Japan 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • Table 27: China Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 28: China 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
  • Table 29: China Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 30: China 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • Table 31: Europe Current & Future Analysis for Legal Marijuana by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 32: Europe 7-Year Perspective for Legal Marijuana by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
  • Table 33: Europe Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 34: Europe 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
  • Table 35: Europe Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 36: Europe 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • Table 37: France Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 38: France 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
  • Table 39: France Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 40: France 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • Table 41: Germany Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 42: Germany 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
  • Table 43: Germany Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 44: Germany 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • Table 45: Italy Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 46: Italy 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
  • Table 47: Italy Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 48: Italy 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • Table 49: UK Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 50: UK 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
  • Table 51: UK Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 52: UK 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • Table 53: Rest of Europe Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 54: Rest of Europe 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
  • Table 55: Rest of Europe Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 56: Rest of Europe 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • Table 57: Asia-Pacific Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 58: Asia-Pacific 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
  • Table 59: Asia-Pacific Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 60: Asia-Pacific 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • Table 61: Rest of World Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 62: Rest of World 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
  • Table 63: Rest of World Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 64: Rest of World 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
IV. COMPETITION
  • Total Companies Profiled: 46
Note: Product cover images may vary from those shown
Adroll
adroll